Key Highlights
- Elon Musk revealed the Terafab initiative will commence in 7 days, establishing a semiconductor production plant at Tesla’s Austin Gigafactory campus
- The manufacturing site aims to prevent a projected chip supply constraint Musk anticipates could restrict Tesla’s expansion within 3–4 years
- Tesla’s ambitious Optimus humanoid robot vision may demand over 200 million semiconductors annually — a 50-fold increase from present requirements
- Morgan Stanley’s Andrew Percoco projects the fabrication facility could demand $35B–$40B in investment with production starting around 2028
- Musk highlighted geopolitical vulnerabilities as a primary motivation for establishing domestic semiconductor manufacturing capabilities
Shares of Tesla climbed 0.6% during early Wednesday market activity, reaching $401.75, following CEO Elon Musk’s announcement that the company’s “Terafab” semiconductor manufacturing plant will commence operations on March 21 at its Austin, Texas Gigafactory location.
Musk initially teased the initiative during a January 2026 earnings call with investors, subsequently confirming the Austin site selection through a March 14 post on the X platform. The semiconductor facility will occupy space within Tesla’s extensive 2,500-acre Gigafactory Texas complex.
The fundamental rationale is straightforward: Musk anticipates Tesla will face semiconductor supply constraints. “When I project ahead and consider what will limit Tesla’s expansion, looking 3 or 4 years forward, I believe it’s actually semiconductor production capacity,” he explained to investors during the January call.
He further identified memory capacity and AI processing power as potential bottlenecks. “Will there be sufficient AI logic capability and adequate memory, enough RAM to support our production volume?” Musk questioned during the discussion.
The Strategic Rationale Behind Tesla’s Chip Manufacturing Move
Morgan Stanley’s Andrew Percoco broke down the calculations. Should Tesla achieve its ambitious long-term objective of manufacturing 100 million-plus Optimus humanoid robots yearly, the company would require upwards of 200 million semiconductors per year. This represents more than a 50-fold multiplication of Tesla’s present chip consumption spanning its automotive and robotaxi divisions.
Percoco noted Tesla’s strategic decision to develop in-house semiconductor production capability stems from dual concerns: geopolitical vulnerabilities and the Optimus robotics initiative. Company leadership indicated AI computational power could become a critical constraint within a three-to-four-year timeframe.
Musk spoke candidly regarding geopolitical considerations. He emphasized the Terafab must encompass “logic chips, memory components and packaging capabilities domestically” to safeguard against supply chain vulnerabilities. “I believe market participants may be underestimating certain geopolitical risks,” he stated.
Constructing a semiconductor fabrication facility demands substantial capital and extended timelines. As a benchmark, Micron’s Boise memory chip plant began construction in 2022 and anticipates initial chip production in 2027.
Financial Investment and Project Magnitude
Percoco projects Tesla may encounter expenditures ranging from $35 billion to $40 billion to establish proprietary chip fabrication capabilities. Even under favorable conditions, he anticipates semiconductor production wouldn’t begin before 2028.
This represents a significant departure from Tesla’s historical capital allocation patterns. The company traditionally allocates under $10 billion annually toward manufacturing facilities and equipment, although it has announced plans to invest $20 billion throughout 2026 as it accelerates its robotics objectives.
Percoco characterized the fabrication facility as a “Herculean undertaking” and suggested Tesla might alternatively pursue partnerships with established semiconductor manufacturers rather than pursuing complete vertical integration. He maintains a Hold rating on Tesla stock with a $415 price objective.
Tesla shares entered Wednesday’s trading session showing an 11% decline year-to-date while demonstrating a 77% gain across the trailing 12-month period. Both S&P 500 and Dow Jones futures registered modest advances during the trading day.
The Terafab facility is scheduled for its official inauguration on March 21.



